ENLIVEX LTD (ENLV) Stock Price & Overview
NASDAQ:ENLV • IL0011319527
The current stock price of ENLV is 1.2 USD. Today ENLV is up by 6.19%. In the past month the price increased by 10.09%. In the past year, price increased by 0.84%.
ENLV Key Statistics
- Market Cap
- 284.856M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.55
- Dividend Yield
- N/A
ENLV Stock Performance
ENLV Stock Chart
ENLV Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to ENLV. When comparing the yearly performance of all stocks, ENLV is a bad performer in the overall market: 64.98% of all stocks are doing better.
ENLV Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ENLV. While ENLV has a great health rating, there are worries on its profitability.
ENLV Earnings
ENLV Forecast & Estimates
8 analysts have analysed ENLV and the average price target is 13.26 USD. This implies a price increase of 1005% is expected in the next year compared to the current price of 1.2.
ENLV Groups
Sector & Classification
ENLV Financial Highlights
Over the last trailing twelve months ENLV reported a non-GAAP Earnings per Share(EPS) of -0.55. The EPS increased by 43.88% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -60.66% | ||
| ROE | -72.66% | ||
| Debt/Equity | 0 |
ENLV Ownership
ENLV Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 16.26 | 413.319B | ||
| AMGN | AMGEN INC | 16.83 | 203.007B | ||
| GILD | GILEAD SCIENCES INC | 16.62 | 183.41B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.44 | 120.332B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.95 | 81.051B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 48.86 | 42.097B | ||
| INSM | INSMED INC | N/A | 31.351B | ||
| NTRA | NATERA INC | N/A | 29.344B | ||
| BIIB | BIOGEN INC | 12.48 | 27.007B | ||
| UTHR | UNITED THERAPEUTICS CORP | 16.41 | 21.856B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 19.914B | ||
| EXAS | EXACT SCIENCES CORP | 309.36 | 19.724B | ||
| MRNA | MODERNA INC | N/A | 19.468B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About ENLV
Company Profile
Enlivex Therapeutics Ltd. engages in the development of macrophage reprogramming immunotherapy products. AllocetraTM is a therapy designed to reprogram macrophages into their homeostatic state. Diseases such as solid cancers, sepsis, COVID-19 and many others reprogram macrophages out of their homeostatic state. These non-homeostatic macrophages contribute significantly to the severity of the respective diseases. By restoring macrophage homeostasis, AllocetraTM has the potential to provide immunotherapeutic mechanism of action for life-threatening clinical indications that are defined as unmet medical needs, as a stand-alone therapy or in combination with therapeutic agents.
Company Info
ENLIVEX LTD
14 Einstein St.
Ness Ziona 7403618 IL
CEO: Oren Hershkovitz
Employees: 36
Phone: 97286623301
ENLIVEX LTD / ENLV FAQ
What does ENLV do?
Enlivex Therapeutics Ltd. engages in the development of macrophage reprogramming immunotherapy products. AllocetraTM is a therapy designed to reprogram macrophages into their homeostatic state. Diseases such as solid cancers, sepsis, COVID-19 and many others reprogram macrophages out of their homeostatic state. These non-homeostatic macrophages contribute significantly to the severity of the respective diseases. By restoring macrophage homeostasis, AllocetraTM has the potential to provide immunotherapeutic mechanism of action for life-threatening clinical indications that are defined as unmet medical needs, as a stand-alone therapy or in combination with therapeutic agents.
What is the current price of ENLV stock?
The current stock price of ENLV is 1.2 USD. The price increased by 6.19% in the last trading session.
Does ENLIVEX LTD pay dividends?
ENLV does not pay a dividend.
What is the ChartMill rating of ENLIVEX LTD stock?
ENLV has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Where is ENLIVEX LTD (ENLV) stock traded?
ENLV stock is listed on the Nasdaq exchange.
Should I buy ENLV stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ENLV.